Ashlee Giesler, NP
Nurse Practitioner · Indianapolis, INNPI 1952768004
Payments from drug & device makers
Across 24 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$95
- Sanofi$84
- Tolmar, Inc.$46
- Hollister Incorporated$43
- Astellas Pharma US Inc$35
- Clarus Therapeutics Inc.$34
- plus $110 from 6 others
What the payments were for
- Food & beverage$448100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 6 | $95 |
| Sanofi | 4 | $84 |
| Tolmar, Inc. | 2 | $46 |
| Hollister Incorporated | 1 | $43 |
| Astellas Pharma US Inc | 2 | $35 |
| Clarus Therapeutics Inc. | 2 | $34 |
| AstraZeneca | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Myovant Sciences Inc. | 1 | $11 |
How this compares
$448 in reported general payments places this provider in the 60th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 14 | $2,206 |
| Hydroxyurea | 51 | $2,067 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 73 | $717 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $379 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $309 |
| Methadone Hcl | 35 | $260 |
| Gabapentin | 21 | $245 |
| Morphine Sulfate | 12 | $215 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 16 | $193 |
| Hydromorphone Hcl | 17 | $121 |
| Tamsulosin Hcl | 15 | $117 |
| Trazodone Hcl | 13 | $10 |
| Cyclobenzaprine Hcl | 13 | $9 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Indianapolis
- Kristi OrbaughIndianapolis$1.3M
- Kacy RogersIndianapolis$77K
- Brittany SavageIndianapolis$51K
- Jennifer MaahsIndianapolis$36K
- Dawn SteppIndianapolis$31K
- Allison FrayerIndianapolis$26K
- Angela PierceIndianapolis$19K
- Donna DoerfflerIndianapolis$13K
- Shannon ColterIndianapolis$12K
- Ellen RovnerIndianapolis$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.